Ochman, Alexander R.;
Lipinski, Christopher A.;
Handler, Jeffrey A.;
Reaume, Andrew G.;
Saporito, Michael S.
The Lyn Kinase Activator MLR-1023 Is a Novel Insulin Receptor Potentiator that Elicits a Rapid-Onset and Durable Improvement in Glucose Homeostasis in Animal Models of Type 2 Diabetes
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
The Lyn Kinase Activator MLR-1023 Is a Novel Insulin Receptor Potentiator that Elicits a Rapid-Onset and Durable Improvement in Glucose Homeostasis in Animal Models of Type 2 Diabetes
Contributor:
Ochman, Alexander R.;
Lipinski, Christopher A.;
Handler, Jeffrey A.;
Reaume, Andrew G.;
Saporito, Michael S.
Published:
American Society for Pharmacology & Experimental Therapeutics (ASPET), 2012
Published in:
Journal of Pharmacology and Experimental Therapeutics, 342 (2012) 1, Seite 23-32